Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REST-ON trial of once-nightly extended-release sodium oxybate in narcolepsy
2016-000359-29Phase 3Completed
- Sponsor
- Avadel Pharmaceuticals
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in narcolepsy, narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2) comparing FT218 with Placebo (2 arms). Primary endpoints: Mean sleep latency on Maintenance of Wakefulness Test, Clinical Global Impression of Improvement and 1 more. Started Jul 2016; status: completed.
02
Drugs
sodium oxybate
03
Conditions
narcolepsynarcolepsy type 1 (NT1)narcolepsy type 2 (NT2)
Beyond the preview
Go deeper on 2016-000359-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000359-29.